News on everything from our latest technology developments to new partnerships and publications.
EpitopePredikt employed to develop novel, epitope based SARS-CoV-2 ELISA assay
In 2020, AiBiologics joined forces with leading scientists and clinicians from the University of Aberdeen, NHS Grampian and it’s partner company Verte
22 April, 2021Artificial Intelligence Technology in COVID-19 Project
Vertebrate Antibodies will utilise its proprietary AI and recombinant technologies to tackle Covid-19. Vertebrate Antibodies Ltd (VAL) is joining forc
03 December, 2020
Use of EpitopePredikt in Lyme disease diagnostics.
EpitopePredikt has been utilised in NorthTick EU project to improve the sensitivity and specificity of existing serological testing methods. Borrelia
25 November, 2020